Skip to main content
SpringerLink
Log in

Early intervention with combined modality therapy for ‘favorable’ non-Hodgkin’s lymphomas of advanced stage

  • Chapter
Book cover Controversies in the Management of Lymphomas

Part of the book series: Cancer Treatment and Research ((CTAR,volume 16))

  • 40 Accesses

Abstract

The non-Hodgkin’s lymphomas encompass a heterogenous group of neoplastic diseases of lymph nodes with varying morphologic, immunologic and clinical subtypes. These malignant lymphomas are known not only for their involvement of lymph nodes but also for their ability to spread and involve extralymphatic organs as well, often in a non-contiguous fashion. However, in the vast majority of patients, the dominant clinical features are lymph node involvement and its’ secondary manifestations of obstruction, pain and possibly organ failure (e.g. hydronephrosis).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kaplan HS: Radiation Therapy. In: Hodgkin’s Disease, Harvard University Press, 1980.

    Google Scholar 

  2. DeVita VT, Simon RM, Hubbard SM et al.: On the curability of advanced Hodgkin’s disease with chemotherapy: Long-term follow-up of MOPP treated patients at NCI and the influences of disease variables on prognosis. Ann Intern Med 92: 587–595, 1980.

    Google Scholar 

  3. Rosenberg SA, Kaplan HS, Hoppe RT, Kushlan P, Horning J: The Stanford randomized trials of the treatment of Hodgkin’s disease: 1967–1980. In: Malignant lymphomas, etiology, immunology, pathology, treatment, Rosenberg SA, Kaplan HS (eds), Academic Press, 1982, pp. 513–522.

    Google Scholar 

  4. DeVita VT, Canellos GP, Chabner B, et al.: Advanced diffuse histocytic lymphoma, a potentially curable disase: Results with combination chemotherapy. Lancet 1: 248–250, 1975.

    Google Scholar 

  5. Fisher RI, DeVita VT, Johnson RL, Berard CW, Young RC: Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. Am J Med 63: 177–182, 1977.

    Article  PubMed  CAS  Google Scholar 

  6. Rosenberg SA, Kaplan HS: Evidence for an orderly progression in the spread of Hodgkin’s disease. Cancer Res 26: 1225–1231, 1966.

    PubMed  CAS  Google Scholar 

  7. Fuks Z, Glatstein E, Kaplan HS: Patterns of presentation and relapse in non-Hodgkin’s lymphomata. Br J Cancer 31: 286–297, 1975.

    Google Scholar 

  8. Kaplan HS, Dorfman RF, Nelson TS, et al.: Staging laparotomy and splenectomy in Hodgkin’s disease: Analysis of indications and patterns of involvement in 285 consecutive unselected patients. Natl Cancer Inst Monogr 36: 291–303, 1973.

    PubMed  CAS  Google Scholar 

  9. Goffinet DR, Warnke R, Dunnick NR, et al.: Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin’s lymphomas. Cancer Treat Rep 61: 981–992, 1977.

    PubMed  CAS  Google Scholar 

  10. Chabner BA, Johnson RE, Young RC et al.: Sequential nonsurgical and surgical staging in non-Hodgkin’s lymphoma. Ann Intern Med 85: 145–154, 1976.

    Google Scholar 

  11. Coller BS, Chabner RA, GralnickHR: Frequencies and patterns of bone marrow involvement in the non-Hodgkin’s lymphomas: Observation on the value of bilateral biopsies. Am J Hematol 3: 105–119, 1979.

    Google Scholar 

  12. Lukes RJ, Craver LF, Hall TC, Rappaport H, Rubin T: Report of the Nomenclature Committee. Cancer Res 26: 1311–1318, 1966.

    Google Scholar 

  13. Torti F, Dorfman RF, Rosenberg SA, Kaplan HS: The Changing significance of histology in Hodgkin’s disease. Proc Am Assoc Cancer Res ASCO 20: 401, 1979.

    Google Scholar 

  14. The non-Hodgkin’s lymphoma pathologic classification project: National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas: summary and description of a working formulation for clinical usage. Cancer 49: 2122–2130, 1982.

    Article  Google Scholar 

  15. Warnke RA, Kim H, Fuks Z, Dorfman RF: The coexistence of nodular and diffuse patterns in nodular non-Hodgkin’s lymphomas. Significance and clinicopathologic correlation. Cancer 40: 1229–1233, 1977.

    Article  PubMed  CAS  Google Scholar 

  16. Goffinet DR, Castellino RA, Kim H, Kaplan HS et al.: Staging laparotomies in unselected previously untreated patients with non-Hodgkin’s lymphomas. Cancer 32: 672–681, 1973.

    Article  PubMed  CAS  Google Scholar 

  17. Anderson T, Bender RA, Fisher RI et al.: Combination chemotherapy in non-Hodgkin’s lymphomas. Results of long-term follow-up. Cancer Treat Rep 61: 1057–1066, 1977.

    PubMed  CAS  Google Scholar 

  18. Longo D, Hubbard S, Wesley M, Young RC: Prolonged initial remission in patients with nodular mixed lymphoma (NML). Proc Am Assoc Cancer Res ASCO 22: 251, 1981.

    Google Scholar 

  19. Glick JH, Barnes JM, Ezoinli EZ et al.: Nodular mixed lymphoma: Results of a randomized trial failing to confirm the prolonged disease-free survival with COPP. Blood, 1981.

    Google Scholar 

  20. Jones SE, Fuks Z, Bull M, Rosenberg SA, Kaplan HS: Non-Hodgkin’s lymphomas IV. Clinicopathologic correlation in 405 cases. Cancer 31: 806–823, 1973.

    Article  PubMed  CAS  Google Scholar 

  21. Portlock CS, Rosenberg SA: No initial therapy for stage III and IV non-Hodgkin’s lymphomas of favorable histologic type. Ann Intern Med 90: 10–13, 1979.

    PubMed  CAS  Google Scholar 

  22. Krikorian JG, Portlock CS, Cooney DP et al.: Spontaneous regression of non-Hodgkin’s lymphoma: A report of nine cases. Cancer 46: 2093–2099, 1980.

    Article  PubMed  CAS  Google Scholar 

  23. Gattiker HH, Wiltshaw E, Galton DAG: Spontaneous regression in non-Hodgkin’s lym-phoma. Cancer 45: 2627–2632, 1980.

    Article  PubMed  CAS  Google Scholar 

  24. Portlock CS: Deferral of initial therapy for advanced indolent lymphomas. Cancer Treat Rep 66: 417–419, 1982.

    PubMed  CAS  Google Scholar 

  25. Goldie JH, Coldman AJ: A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63: 1727–1733, 1979.

    PubMed  CAS  Google Scholar 

  26. Cullen MH, Lister TH, Brearley RL et al.: Histological transformation of non-Hodgkin’s lymphoma: A prospective study. Cancer 44: 645–651, 1979.

    Article  PubMed  CAS  Google Scholar 

  27. Jones R, Young RC, Berard CW et al.: Histologic progression in non-Hodgkin’s lymphoma. Implications for survival and clinical trials. Proc Am Assoc Cancer Res ASCO 20: 253, 1979.

    Google Scholar 

  28. Jones SE, Rosenberg SA, Kaplan HS, Kadin ME, Dorfman RF: Non-Hodgkin’s lymphoma. II. Single-agent chemotherapy. Cancer 30: 31–38, 1972.

    Article  PubMed  CAS  Google Scholar 

  29. Portlock CS, Rosenberg SA: Chemotherapy of non-Hodgkin’s lymphomas: The Stanford experience. Cancer Treat Rep 61–1049–1054,1977.

    Google Scholar 

  30. Hoppe RT, Kushlan P, Kaplan HS et al.: The treatment of advanced stage favorable histology non-Hodgkin’s lymphoma: A preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation. Blood 58: 592–598, 1981.

    PubMed  CAS  Google Scholar 

  31. Glatstein E, Donaldson JS, Rosenberg SA et al.: Combined modality therapy in malignant lymphomas. Cancer Treat Rep 61: 1199–1227, 1977.

    Google Scholar 

  32. Schein PS, Chabner BA, Canellos GP et al.: Non-Hodgkin’s lymphoma: Patterns of relapse from complete remission after combination chemotherapy. Cancer 35: 354–357, 1975.

    Article  PubMed  CAS  Google Scholar 

  33. Fuks Z, Kaplan HS: Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. Radiology 108: 675–684, 1973.

    PubMed  CAS  Google Scholar 

  34. Glatstein E, Fuks Z, Goffinet DR et al.: Non-Hodgkin’s lymphomas of stage III extent: Is total lymphoid irradiation appropriate treatment? Cancer 37: 2806–2812, 1976.

    Article  PubMed  CAS  Google Scholar 

  35. Young RC, Johnson RE, Canellos GP et al.: Advanced lymphocytic lymphoma: Randomized comparisons of chemotherapy and radiotherapy, alone or in combination. Cancer Treat Rep 61: 1153–1159, 1977.

    PubMed  CAS  Google Scholar 

  36. Cox JD, Komaki R, Kun LE et al.: Stage III nodular lymphoreticular tumors (non-Hodgkin’s lymphoma). Results of central lymphatic irradiation. Cancer 47: 2247–2252, 1981.

    Article  PubMed  CAS  Google Scholar 

  37. Johnson RE: Management of generalized malignant lymphomata with ‘systemic’ radiotherapy. Br J Cancer (Suppl II) 31: 450–455, 1975.

    Google Scholar 

  38. Chaffey JT, Hellman S, Rosenthal DS, Maloney WC: Total body irradiation in the treatment of lymphocytic lymphoma. Cancer Treat Rep 61: 1149–1154, 1977.

    PubMed  CAS  Google Scholar 

  39. Carabell SC, Chaffey JT, Rosenthal DS et al.: Results of total body irradiation in the treatment of advanced non-Hodgkin’s lymphomas. Cancer 43: 994–1000, 1979.

    Article  PubMed  CAS  Google Scholar 

  40. Coleman CM, Williams CJ, Flint A et al.: Hematologic neoplasia in patients treated for Hodgkin’s disease. N Engl J Med 297: 1249–1252, 1977.

    Article  PubMed  CAS  Google Scholar 

  41. Coleman CN, Burke JS, Varghese A, Rosenberg SA, Kaplan HS: Secondary leukemia and non-Hodgkin’s lymphoma in patients treated for Hodgkin’s disease. In: Advances in Malignant Lymphomas, Rosenberg SA, Kaplan HS (eds), Academic Press, 1982, p. 259–275.

    Google Scholar 

  42. Portlock CS, Rosenberg SA, Glatstein E et al.: Treatment of advanced non-Hodgkin’s lymphomas. Preliminary results of a prospective trial. Blood 47: 747–756, 1976.

    PubMed  CAS  Google Scholar 

  43. Hoppe RT, Portlock CS, Rosenberg SA et al.: Alternating chemotherapy and irradiation in treatment of advanced Hodgkin’s disease. Cancer 43: 472–481, 1979.

    Article  PubMed  CAS  Google Scholar 

  44. Kinsella TJ, Bloomer W: Tolerance of the intestine to radiation therapy. Surg Gynecol Obstet 151: 273–284, 1980.

    PubMed  CAS  Google Scholar 

  45. Kinsella TJ, Fraass BA, Glatstein E: Late effects of radiation therapy in the treatment of Hodgkin’s disease. Cancer Treat Rep 66: 991–1001, 1982.

    PubMed  CAS  Google Scholar 

  46. Sieber SM, Correa P, Dalgard PW et al.: Carcinogenic and other adverse effects of procarbazine. Cancer Res 38: 2125–2134, 1978.

    PubMed  CAS  Google Scholar 

  47. Green MH, Young RC, Glatstein E et al.: Acute nonlymphocytic leukemia (ANL) following treatment of non-Hodgkin’s lymphoma. Proc Am Assoc Cancer Res ASCO 22: 515, 1981.

    Google Scholar 

Download references

Authors
  1. Timothy J. Kinsella
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Oncology Division, Cancer Center of the University of Rochester Medical Center, Rochester, New York, USA

    John M. Bennett M.D. (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Martinus Nijhoff Publishers, Boston.

About this chapter

Cite this chapter

Kinsella, T.J. (1983). Early intervention with combined modality therapy for ‘favorable’ non-Hodgkin’s lymphomas of advanced stage. In: Bennett, J.M. (eds) Controversies in the Management of Lymphomas. Cancer Treatment and Research, vol 16. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3885-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-3885-7_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-3887-1

  • Online ISBN: 978-1-4613-3885-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation